Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Interest Expenses (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Interest Expenses came in at $11 million for Q2 2026, up 205.6% from $3.6 million a year earlier but down 14.7% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Interest Expenses (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Regeneron Pharmaceuticals reported Interest Expenses of $55.4 million, up 51.4% year-over-year; for FY2025, it came in at $43.8 million, down 20.7% from FY2024.

  • Interest Expenses carries a five-year compound annual growth rate of -5.1% (FY2020 to FY2025).
  • Going back by year, Interest Expenses was $55.2 million in FY2024 (-24.4%), $73 million in FY2023 (+22.9%), $59.4 million in FY2022 (+3.7%) and $57.3 million in FY2021 (+0.7%).
  • The five-year range for quarterly Interest Expenses is $3.6 million (Q2 2025) to $19.3 million (Q3 2025).
  • Year-over-year, Interest Expenses has increased for four consecutive quarters, with growth averaging 15.4% over the last eight quarters.
  • The fastest year-over-year change in Interest Expenses over five years came in Q2 2026 (growth of 205.6%), and the weakest in Q2 2025 (a decline of 75.7%).
  • Business Quant data shows REGN's Interest Expenses at $12.9 million (Q1 2026), $12.2 million (Q4 2025) and $19.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 281.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 435.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 247.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 11.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.00 Mn
Mar 31, 2026 12.90 Mn
Dec 31, 2025 12.20 Mn
Sep 30, 2025 19.30 Mn
Jun 30, 2025 3.60 Mn
Mar 31, 2025 8.70 Mn
Dec 31, 2024 10.50 Mn
Sep 30, 2024 13.80 Mn
Jun 30, 2024 14.80 Mn
Mar 31, 2024 16.10 Mn
Dec 31, 2023 18.30 Mn
Sep 30, 2023 17.80 Mn
Jun 30, 2023 18.90 Mn
Mar 31, 2023 18.00 Mn
Dec 31, 2022 17.40 Mn
Sep 30, 2022 15.30 Mn
Jun 30, 2022 13.10 Mn
Mar 31, 2022 13.60 Mn
Dec 31, 2021 14.10 Mn
Sep 30, 2021 14.20 Mn
API Access

Regeneron Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=REGN&period=max&api_key=YOUR_API_KEY